Eisai Wins Approval Of Sedative Lusedra, But Without Main Marketing Advantage
This article was originally published in The Pink Sheet Daily
Executive Summary
Company was hoping to position Lusedra as an anesthetic that did not require the presence of an anesthesiologist.